Nothing Special   »   [go: up one dir, main page]

WO2004065542A3 - Mat2a utilises comme modificateurs de la voie p53 et procedes d'utilisation - Google Patents

Mat2a utilises comme modificateurs de la voie p53 et procedes d'utilisation Download PDF

Info

Publication number
WO2004065542A3
WO2004065542A3 PCT/US2003/041439 US0341439W WO2004065542A3 WO 2004065542 A3 WO2004065542 A3 WO 2004065542A3 US 0341439 W US0341439 W US 0341439W WO 2004065542 A3 WO2004065542 A3 WO 2004065542A3
Authority
WO
WIPO (PCT)
Prior art keywords
pathway
methods
mat2as
modifiers
mat2a
Prior art date
Application number
PCT/US2003/041439
Other languages
English (en)
Other versions
WO2004065542A2 (fr
Inventor
Marcia Belvin
Helen Francis-Lang
Lori Friedman
Gregory D Plowman
Kim Lickteig
Original Assignee
Exelixis Inc
Marcia Belvin
Helen Francis-Lang
Lori Friedman
Gregory D Plowman
Kim Lickteig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc, Marcia Belvin, Helen Francis-Lang, Lori Friedman, Gregory D Plowman, Kim Lickteig filed Critical Exelixis Inc
Priority to AU2003303094A priority Critical patent/AU2003303094A1/en
Publication of WO2004065542A2 publication Critical patent/WO2004065542A2/fr
Publication of WO2004065542A3 publication Critical patent/WO2004065542A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne des gènes MAT2A humains qui ont été identifiés comme modulateurs de la voie p53 et qui constituent par conséquent des cibles thérapeutiques dans les troubles associés à une fonction p53 défaillante. L'invention se rapporte à des procédés permettant d'identifier des modulateurs de p53, qui consistent à effectuer un criblage à la recherche d'agents modulant l'activité de MAT2A.
PCT/US2003/041439 2002-12-30 2003-12-29 Mat2a utilises comme modificateurs de la voie p53 et procedes d'utilisation WO2004065542A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003303094A AU2003303094A1 (en) 2002-12-30 2003-12-29 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43716202P 2002-12-30 2002-12-30
US60/437,162 2002-12-30

Publications (2)

Publication Number Publication Date
WO2004065542A2 WO2004065542A2 (fr) 2004-08-05
WO2004065542A3 true WO2004065542A3 (fr) 2004-12-29

Family

ID=32771743

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/041439 WO2004065542A2 (fr) 2002-12-30 2003-12-29 Mat2a utilises comme modificateurs de la voie p53 et procedes d'utilisation

Country Status (2)

Country Link
AU (1) AU2003303094A1 (fr)
WO (1) WO2004065542A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018006781A (es) 2015-12-03 2018-11-09 Agios Pharmaceuticals Inc Inhibidores de mat2a para el tratamiento del cancer que no expresen mtap.
EP3507290A1 (fr) 2016-08-31 2019-07-10 Agios Pharmaceuticals, Inc. Inhibiteurs de processus métaboliques cellulaires

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142981A1 (en) * 2000-06-14 2002-10-03 Horne Darci T. Gene expression profiles in liver cancer
US20030082511A1 (en) * 2001-09-25 2003-05-01 Brown Steven J. Identification of modulatory molecules using inducible promoters
US20030109690A1 (en) * 1999-09-29 2003-06-12 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
US6596701B1 (en) * 1995-04-25 2003-07-22 Mediquest Therapeutics, Inc. S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596701B1 (en) * 1995-04-25 2003-07-22 Mediquest Therapeutics, Inc. S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US20030109690A1 (en) * 1999-09-29 2003-06-12 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
US20020142981A1 (en) * 2000-06-14 2002-10-03 Horne Darci T. Gene expression profiles in liver cancer
US20030082511A1 (en) * 2001-09-25 2003-05-01 Brown Steven J. Identification of modulatory molecules using inducible promoters

Also Published As

Publication number Publication date
WO2004065542A2 (fr) 2004-08-05
AU2003303094A8 (en) 2004-08-13
AU2003303094A1 (en) 2004-08-13

Similar Documents

Publication Publication Date Title
WO2002099047A3 (fr) Genes proml en tant que modificateurs de la voie p53 et procedes d'utilisation associes
WO2002098356A3 (fr) Genes de ppp2c en tant que modificateurs de la voie p53 et methodes d'utilisation
WO2003073823A3 (fr) Pdpk1 utilises en tant que modificateurs de la voie p53 et procedes d'utilisation associes
WO2003014301A3 (fr) Hprp4 en tant que modificateurs de la voie de passage p53 leurs et methodes d'utilisation
WO2003051905A3 (fr) Taojik utilises en tant que modificateurs de la voie beta-catenine et procedes d'utilisation associes
WO2002099043A8 (fr) P5crs identifies comme des modificateurs de la voie p53 et procedes d'utilisation
WO2004024882A3 (fr) Flj20647 utilise en tant que modificateur de la voie p21 et procedes d'utilisation associes
WO2003035831A3 (fr) Lrrcaps en tant que modificateurs de la voie de passage p53 et leurs procedes d'utilisation
WO2004065542A3 (fr) Mat2a utilises comme modificateurs de la voie p53 et procedes d'utilisation
WO2004014301A3 (fr) Genes psmc utilises comme modificateurs du trajet retiniblastome (rb) et techniques d'utilisation
WO2004015071A3 (fr) Genes csnk1gs utilises en tant que modificateurs de la voie p21 et procede d'utilisation associe
WO2004015069A3 (fr) Mp2153 comme genes modificateurs de la voie de p21 ou de p53 et procedes d'utilisation
WO2003074725A3 (fr) Mbcat comme modificateurs du mecanisme d'action de la $g(b)-catenine et procedes d'utilisation correspondants
WO2004061123A3 (fr) Mbcat servant de modificateurs de la voie de beta-catenine et leurs procedes d'utilisation
WO2003052068A3 (fr) Genes mbcat agissant comme modificateurs du mecanisme d'action de la beta-catenine et methodes d'utilisation
WO2004048541A3 (fr) Cct6 utilises comme modificateurs de la voie rb, et procedes d'utilisation correspondants
WO2004083389A3 (fr) Genes mbcat utilises comme modificateurs de la voie de la beta-catenine et techniques d'utilisation
WO2003052066A3 (fr) Klcs utilises en tant que genes modificateurs de la voie p53 et procedes d'utilisation correspondant
WO2004024881A3 (fr) Ldlr utilise en tant que modificateur de la voie p53 et procedes d'utilisation associes
WO2003066811A3 (fr) Genes msrebp utilises en tant que modificateurs de la voie des proteines srebp, et procedes d'utilisation associes
WO2003074671A3 (fr) Mbcat tenant lieu de modificateurs de la voie d'une beta-catenine et leurs procedes d'utilisation
WO2004047761A3 (fr) Genes mbcat en tant que modificateurs de la voie beta-catenine et leurs procedes d'utilisation
WO2005003306A3 (fr) Sppls utilises en tant que modificateurs de la voie p53 et procedes d'utilisation
WO2004104168A3 (fr) Mrb utilises comme modificateurs de la voie des rb et procedes d'utilisation correspondants
WO2004083447A3 (fr) Mbcat en tant que modificateurs de la voie de la beta-catenine et methodes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP